ClinicalTrials.gg
CompletedNCT07375927RCR-KTUpdated Sep 30, 2026

Effect of Kinesio Taping After Rotator Cuff Surgery

An interventional study of Kinesio Taping and Standard Postoperative Rehabilitation in Rotator Cuff Tears, Shoulder Pain and Post Operative Pain, sponsored by Olcay Yavuz. Completed at 1 site in Turkey (Türkiye). Open to participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Olcay Yavuz · Not applicable, Interventional, and Treatment

How we know

Updated Sep 30, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
40 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 85 studies in Rotator Cuff Injuries with a site in Turkey — 19 open to participants now, 22 under way, none of them phase 3. Rotator Cuff Injuries · Turkey.

Enrollment
21st of 63
52 · median 44
Started
2026
with 12 others
No phase
63 of 85
11 open now
Registered
74th of 85
by date

Among the 85 studies in Rotator Cuff Injuries with a site in Turkey, this one is the 21st largest by enrollment of the 63 interventional ones that give a count, is one of 13 that started in 2026, is one of 63 with no phase, and was the 74th registered.

Rotator Cuff Injuries

632 studies on the registry are indexed under Rotator Cuff Injuries; 157 are open to participants now.

Browse Rotator Cuff Injuries studies →

Open to participants now

19 of the 85 studies in Rotator Cuff Injuries with a site in Turkey are open now. Recruiting first, the newest first:

14 more — sign in →

All 19 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 100 Rotator Cuff Injuries studies recruiting now, 40 (40%) set no upper age limit and 41 (41%) stop at 75 or younger; 9 take children under 18; 10 take healthy volunteers.

This study: 40 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 85 studies in Rotator Cuff Injuries with a site in Turkey, or all of them as a file.
02

Study summary

This prospective randomized controlled trial evaluated whether adding Kinesio Taping (KT) to a standardized postoperative rehabilitation program improves early clinical recovery after arthroscopic rotator cuff repair. Patients undergoing arthroscopic repair of an isolated full-thickness supraspinatus tear were randomized to receive either standardized rehabilitation combined with KT or standardized rehabilitation alone. Postoperative pain intensity was the primary outcome. Secondary outcomes included shoulder range of motion, postoperative edema, Constant-Murley Score, QuickDASH score, and postoperative complications. Participants were assessed preoperatively and on postoperative day 1, week 2, week 6, and month 3.

Read the detailed description

This prospective, randomized controlled trial was designed to evaluate the effects of adding postoperative Kinesio Taping (KT) to a standardized rehabilitation program on pain, edema, shoulder range of motion, and functional recovery after arthroscopic rotator cuff repair.

Patients aged 40-70 years who underwent arthroscopic repair of an isolated full-thickness supraspinatus tear measuring 1-3 cm in the mediolateral dimension were eligible for inclusion. Tear size was confirmed intraoperatively using a calibrated arthroscopic probe. Only tears with Patte grade I-II tendon retraction and Goutallier grade 2 or lower fatty degeneration were included.

Patients with massive or multiple-tendon rotator cuff tears, subscapularis involvement, previous surgery on the affected shoulder, glenohumeral arthritis, systemic inflammatory disease, diabetes mellitus, smoking history, or a known allergy to adhesive or kinesiology tape were excluded.

After providing written informed consent, eligible participants were randomly assigned to one of two treatment groups using a computer-generated block randomization sequence with variable block sizes. Allocation concealment was maintained using sequentially numbered, sealed, opaque envelopes.

Participants in the intervention group received KT for 3 weeks in addition to the standardized postoperative rehabilitation program. KT was initiated on postoperative day 1 and reapplied every three days during the first four postoperative weeks, with each application maintained continuously for approximately 72 hours. Participants in the control group followed the same standardized postoperative rehabilitation program without taping. All KT applications were performed by the same certified physiotherapist using a standardized technique.

Because of the visible nature of the intervention, participants and outcome assessors were not blinded to group allocation. However, the assessors were not involved in generating the randomization sequence or concealing treatment allocation.

The primary outcome was postoperative pain intensity measured using the Visual Analog Scale (VAS). Secondary outcomes included shoulder forward flexion and abduction, postoperative edema, shoulder function measured using the Constant-Murley Score, upper-extremity disability measured using the QuickDASH questionnaire, and postoperative complications, including tape-related skin reactions.

Postoperative edema was assessed by measuring the circumference of the operated shoulder at a standardized point in the deltoid region and comparing it with the contralateral shoulder. Shoulder range of motion was measured using a standard goniometer. Each range-of-motion measurement was repeated three times, and the mean value was recorded.

Clinical assessments were performed preoperatively and on postoperative day 1, week 2, week 6, and month 3. Outcomes were compared between the two groups and evaluated longitudinally to determine whether the addition of KT influenced the pattern of early postoperative recovery following arthroscopic rotator cuff repair.

03

Conditions studied

  • Rotator Cuff Tears
  • Shoulder Pain
  • Post Operative Pain

Keywords

  • Rotator Cuff Tears
  • Kinesio Taping
  • Arthroscopic Rotator Cuff Repair
  • Postoperative Rehabilitation
04

Who can participate

The criteria were revised on the registry on Sep 30, 2026. See what changed

Ages eligible
40 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals aged between 40 and 70 years
  • Patients with clinical suspicion of rotator cuff tear on physical examination and a diagnosis established by magnetic resonance imaging, with intraoperative confirmation
  • Patients with at least two positive impingement tests on physical examination (Jobe, Hawkins-Kennedy, Neer)
  • Patients without a diagnosed psychiatric disorder
  • Patients without a history or current diagnosis of cervical pathology
  • Patients with a Visual Analog Scale (VAS) score of 3 or higher for at least 3 months prior to surgery
  • Patients able to participate regularly in postoperative follow-up for a period of one year
  • Patients who agree to participate voluntarily and provide written

Exclusion criteria

Exclusion Criteria:

  • History of shoulder dislocation
  • History of fracture involving the shoulder or surrounding structures
  • Inability to comply with postoperative treatment or attend regular follow-up visits
  • Known skin or allergy to kinesio taping
  • Known rheumatologic or neurological disease
  • History of previous shoulder or peri-shoulder surgery
  • Presence of cervical disc pathology
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
52 participants (actual)

Study arms

  • Experimental
    Kinesio Taping Group

    Participants in this group will receive standard postoperative rehabilitation following arthroscopic rotator cuff repair, in addition to kinesio taping applied for three weeks during the postoperative period.

    Procedure: Kinesio Taping · Procedure: Standard Postoperative Rehabilitation

  • Active comparator
    Control Group

    Participants in this group will receive standard postoperative rehabilitation alone following arthroscopic rotator cuff repair, without the application of kinesio taping.

    Procedure: Standard Postoperative Rehabilitation

Interventions

  • ProcedureKinesio Taping

    Application of kinesio taping to the operated shoulder during the postoperative period as an adjunct to standard rehabilitation.

  • ProcedureStandard Postoperative Rehabilitation

    Standard postoperative rehabilitation program following arthroscopic rotator cuff repair.

06

What researchers measure

Primary outcomes

  1. Pain Intensity (Visual Analog Scale, VAS)

    Pain intensity will be assessed using the Visual Analog Scale (VAS) for pain, ranging from 0 to 10, where 0 indicates no pain and 10 indicates worst imaginable pain. Higher scores indicate worse pain intensity.

    Time frame: Postoperative day 1, week 2, week 6, and month 3

Secondary outcomes

  1. Forward Flexion

    Active forward flexion of the affected shoulder will be measured in degrees using a goniometer. The participant will raise the arm sideways as far as possible without assistance. At each assessment time point, the measurement will be repeated three times, and the mean of the three values will be recorded. The measured angle will be recorded from 0° to 180°, with higher values indicating greater shoulder range of motion. Change from baseline will be calculated at each prespecified follow-up visit.

    Time frame: Postoperative day 1, week 2, week 6, and month 3

  2. Abduction

    Active abduction of the affected shoulder will be measured in degrees using a goniometer. The participant will raise the arm sideways as far as possible without assistance. At each assessment time point, the measurement will be repeated three times, and the mean of the three values will be recorded. The measured angle will be recorded from 0° to 180°, with higher values indicating greater shoulder range of motion. Change from baseline will be calculated at each prespecified follow-up visit.

    Time frame: Postoperative day 1, week 2, week 6, and month 3

  3. Postoperative Edema Assessed by Relative Shoulder Circumference

    Postoperative edema was assessed circumferentially using a non-elastic measuring tape at a standardized point corresponding to the midpoint of the deltoid region. The contralateral shoulder served as the reference. Relative edema was expressed as a percentage and calculated as: \[(operated-side circumference - contralateral-side circumference) / contralateral-side circumference\] × 100. A value of 0% indicated equal circumference between shoulders. Higher positive values indicated greater postoperative edema and a worse outcome, whereas values closer to 0% indicated less edema and a better outcome.

    Time frame: Postoperative day 1, week 2, week 6, and month 3

  4. Shoulder Function (Constant-Murley Score)

    Shoulder function was assessed using the Constant-Murley Score, which evaluates pain (0-15 points), activities of daily living (0-20 points), range of motion (0-40 points), and strength (0-25 points). The total score ranges from 0 to 100 points. Higher scores indicate better shoulder function and therefore a better outcome, whereas lower scores indicate greater impairment and a worse outcome.

    Time frame: Postoperative day 1, week 2, week 6, and month 3

  5. Upper Extremity Function (QuickDASH Score)

    Upper extremity function and disability will be assessed using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. The QuickDASH score ranges from 0 to 100, with higher scores indicating greater upper extremity disability and therefore worse functional outcome.

    Time frame: Postoperative day 1, week 2, week 6, and month 3

  6. Postoperative Complications

    Postoperative complications, including wound problems, infection, clinically important shoulder stiffness, repair-related complications, and tape-related skin reactions, will be recorded. The outcome will be reported as the number and percentage of participants who experience one or more postoperative complications.

    Time frame: From the date of surgery through postoperative month 3

07

Study locations

1 site
  • Fatih Sultan Mehmet Training and Research Hospital
    Istanbul, 34785, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared other researchers.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2026 to primary completion in Jul 2026, 5 months.

Of 228 non-industry interventional studies with no phase under Rotator Cuff Injuries, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's 5 months is below that.

Counting every sponsor, half of 252 studies reached it within 23 months; a quarter within 11 and three quarters within 44.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 30, 2026: start Dec 2025 → Feb 2026 and primary completion Jun 2026 → Jul 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 22, 2026
First posted
Jan 29, 2026
StartActual
Feb 1, 2026was Dec 2025
Primary completionActual
Jul 28, 2026was Jun 2026
CompletionActual
Jul 30, 2026
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Dec 30, 2025→Feb 1, 2026
Sep 30, 2026
Primary completion
Jun 30, 2026→Jul 28, 2026
Sep 30, 2026
Eligibility
Minimum age 18 Years→40 Years; 1 inclusion criterion edited
What changed in the criteria
Inclusion criteria
  • EditedIndividuals aged between 1840 and 70 years
Sep 30, 2026
Secondary outcomes
2 added, 1 removed
What changed in the outcomes
  • AddedForward FlexionTime frame: Postoperative day 1, week 2, week 6, and month 3
  • AddedAbductionTime frame: Postoperative day 1, week 2, week 6, and month 3
  • RemovedShoulder Range of MotionTime frame: Postoperative day 1, week 2, week 6, and month 3
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    Start date Dec 30, 2025→Feb 1, 2026
    Primary completion Jun 30, 2026→Jul 28, 2026
    Eligibility Minimum age 18 Years→40 Years; 1 inclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • EditedIndividuals aged between 1840 and 70 years
    Secondary outcomes 2 added, 1 removed
    What changed in the outcomes
    • AddedForward FlexionTime frame: Postoperative day 1, week 2, week 6, and month 3
    • AddedAbductionTime frame: Postoperative day 1, week 2, week 6, and month 3
    • RemovedShoulder Range of MotionTime frame: Postoperative day 1, week 2, week 6, and month 3
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07375927
Lead sponsor
Olcay Yavuz
Responsible party
Olcay Yavuz (Medical Doctor, Orthopedic Surgery Resident, Fatih Sultan Mehmet Training and Research Hospital) — Sponsor-investigator
First posted
Jan 29, 2026
Start date
Feb 1, 2026
Primary completion
Jul 28, 2026
Completion
Jul 30, 2026
Last update
Sep 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion